LRHC vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

LRHC

55.5
AI Score
VS
NIVF Wins

NIVF

59.7
AI Score

Investment Advisor Scores

LRHC

56score
Recommendation
HOLD

NIVF

60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LRHC NIVF Winner
Forward P/E 0 0.0396 Tie
PEG Ratio 0 0 Tie
Revenue Growth -7.2% 11.9% NIVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 55.5/100 59.7/100 NIVF
Profit Margin 76.7% 209.0% NIVF
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LRHC 1M: -42.0% · 3M: -58.3% NIVF 1M: -52.3% · 3M: -48.1%

Current Technical Phase

LRHC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -17.1%), weak momentum, RSI 32

RSI (14): 32.1 · Price: $0.59

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.7%), weak momentum, RSI 38

RSI (14): 38.1 · Price: $0.58

Fundamentals Snapshot

Metric LRHC NIVF
Market Cap
Forward P/E 0.0 0.0
Trailing P/E 0.0 0.0
Revenue (TTM)
Revenue Growth -0.1% 0.1%
Gross Margin 0.1% 0.2%
Operating Margin -0.2% -3.5%
EPS 44072.79 108.08
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.